Skip to main content
OpenTrials
Completed

NCT Number: NCT01764204

Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

To highlight the incidence of adverse reactions of Qingkailing Injection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adverse Drug Events Adverse Drug Reactions Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions

Age range

1 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Defense University Hospital of People's Liberation Army, Beijing, Beijing Municipality, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
  • in accordance with ethics requirements.

Exclusion criteria

  • none.

Treatment and study plan

Qingkailing Injection

Drug

Qingkailing Injection is a kind of natural product injection made from Chinese herbs, which has been used to treat cerebral ischemia for decades in China. The main bioactive ingredients of this injection include Baicalin, Jasminoidin, Ursodeoxycholic Acid, Concha Margaritifera,etc.

Other names: Shineway Qingkailing Injection

Primary outcomes

  1. incidence of severe adverse drug reactions

    Time frame: 2 years

Secondary outcomes

  1. incidence of adverse drug reactions

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

China Academy of Chinese Medical Sciences

Other

Registry information

Official study title

Intensive Hospital-based Adverse Drug Reaction Monitoring Study On Patients Treated By Qingkailing Injection In The Next Two Years

Important dates

Study start
2013
Primary completion
2017
Study completion
2018
First posted
Jan 9, 2013
Registry last updated
Feb 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.